181 related articles for article (PubMed ID: 37887278)
1. Aurora Kinase A Regulates Cell Transitions in Glucocorticoid-Induced Bone Loss.
Qiao X; Yang Y; Zhao Y; Wu X; Zhang L; Cai X; Ji J; Boström KI; Yao Y
Cells; 2023 Oct; 12(20):. PubMed ID: 37887278
[TBL] [Abstract][Full Text] [Related]
2. Cell Transitions Contribute to Glucocorticoid-Induced Bone Loss.
Qiao X; Wu X; Zhao Y; Yang Y; Zhang L; Cai X; Ma JA; Ji J; Lyons K; Boström KI; Yao Y
Cells; 2023 Jul; 12(14):. PubMed ID: 37508475
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoid receptor 1 regulates ERK and GSK-3β-dependent glucocorticoid inhibition of osteoblast differentiation in murine MC3T3-E1 cells.
Wu RW; Lin TP; Ko JY; Yeh DW; Chen MW; Ke HC; Wu SL; Wang FS
Bone; 2011 Dec; 49(6):1255-63. PubMed ID: 21914493
[TBL] [Abstract][Full Text] [Related]
4. Let-7f-5p regulates TGFBR1 in glucocorticoid-inhibited osteoblast differentiation and ameliorates glucocorticoid-induced bone loss.
Shen GY; Ren H; Shang Q; Zhao WH; Zhang ZD; Yu X; Huang JJ; Tang JJ; Yang ZD; Liang D; Jiang XB
Int J Biol Sci; 2019; 15(10):2182-2197. PubMed ID: 31592234
[TBL] [Abstract][Full Text] [Related]
5. Heat shock protein 60 protects skeletal tissue against glucocorticoid-induced bone mass loss by regulating osteoblast survival.
Wang FS; Wu RW; Ko JY; Tai MH; Ke HC; Yeh DW; Wu SL; Chen MW
Bone; 2011 Nov; 49(5):1080-9. PubMed ID: 21854881
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of glycogen synthase kinase-3beta attenuates glucocorticoid-induced bone loss.
Wang FS; Ko JY; Weng LH; Yeh DW; Ke HJ; Wu SL
Life Sci; 2009 Nov; 85(19-20):685-92. PubMed ID: 19782693
[TBL] [Abstract][Full Text] [Related]
7. Glucocorticoids induce osteoporosis mediated by glucocorticoid receptor-dependent and -independent pathways.
Jiang Y; Lu Y; Jiang X; Hu J; Li R; Liu Y; Zhu G; Rong X
Biomed Pharmacother; 2020 May; 125():109979. PubMed ID: 32044718
[TBL] [Abstract][Full Text] [Related]
8. Evidence supporting a role of glucocorticoids in short-term bone loss in burned children.
Klein GL; Bi LX; Sherrard DJ; Beavan SR; Ireland D; Compston JE; Williams WG; Herndon DN
Osteoporos Int; 2004 Jun; 15(6):468-74. PubMed ID: 15205718
[TBL] [Abstract][Full Text] [Related]
9. Dicer ablation in osteoblasts by Runx2 driven cre-loxP recombination affects bone integrity, but not glucocorticoid-induced suppression of bone formation.
Liu P; Baumgart M; Groth M; Wittmann J; Jäck HM; Platzer M; Tuckermann JP; Baschant U
Sci Rep; 2016 Aug; 6():32112. PubMed ID: 27554624
[TBL] [Abstract][Full Text] [Related]
10. Mineralocorticoid receptor function in bone metabolism and its role in glucocorticoid-induced osteopenia.
Fumoto T; Ishii KA; Ito M; Berger S; Schütz G; Ikeda K
Biochem Biophys Res Commun; 2014 May; 447(3):407-12. PubMed ID: 24713303
[TBL] [Abstract][Full Text] [Related]
11. The Glucocorticoid Receptor in Osterix-Expressing Cells Regulates Bone Mass, Bone Marrow Adipose Tissue, and Systemic Metabolism in Female Mice During Aging.
Pierce JL; Sharma AK; Roberts RL; Yu K; Irsik DL; Choudhary V; Dorn JS; Bensreti H; Benson RD; Kaiser H; Khayrullin A; Davis C; Wehrle CJ; Johnson MH; Bollag WB; Hamrick MW; Shi X; Isales CM; McGee-Lawrence ME
J Bone Miner Res; 2022 Feb; 37(2):285-302. PubMed ID: 34747055
[TBL] [Abstract][Full Text] [Related]
12. Glucocorticoids suppress bone formation by attenuating osteoblast differentiation via the monomeric glucocorticoid receptor.
Rauch A; Seitz S; Baschant U; Schilling AF; Illing A; Stride B; Kirilov M; Mandic V; Takacz A; Schmidt-Ullrich R; Ostermay S; Schinke T; Spanbroek R; Zaiss MM; Angel PE; Lerner UH; David JP; Reichardt HM; Amling M; Schütz G; Tuckermann JP
Cell Metab; 2010 Jun; 11(6):517-31. PubMed ID: 20519123
[TBL] [Abstract][Full Text] [Related]
13. Cannabinoid receptor 1 mediates glucocorticoid-induced bone loss in rats by perturbing bone mineral acquisition and marrow adipogenesis.
Ko JY; Wu RW; Kuo SJ; Chen MW; Yeh DW; Ke HC; Wu SL; Wang FS
Arthritis Rheum; 2012 Apr; 64(4):1204-14. PubMed ID: 22127784
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-29a protects against glucocorticoid-induced bone loss and fragility in rats by orchestrating bone acquisition and resorption.
Wang FS; Chuang PC; Lin CL; Chen MW; Ke HJ; Chang YH; Chen YS; Wu SL; Ko JY
Arthritis Rheum; 2013 Jun; 65(6):1530-40. PubMed ID: 23529662
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-29a ameliorates glucocorticoid-induced suppression of osteoblast differentiation by regulating β-catenin acetylation.
Ko JY; Chuang PC; Chen MW; Ke HC; Wu SL; Chang YH; Chen YS; Wang FS
Bone; 2013 Dec; 57(2):468-75. PubMed ID: 24096265
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of heat shock protein 90 rescues glucocorticoid-induced bone loss through enhancing bone formation.
Chen H; Xing J; Hu X; Chen L; Lv H; Xu C; Hong D; Wu X
J Steroid Biochem Mol Biol; 2017 Jul; 171():236-246. PubMed ID: 28408351
[TBL] [Abstract][Full Text] [Related]
17. Genetic approaches to determine the role of glucocorticoid signaling in osteoblasts.
Harrison JR; Woitge HW; Kream BE
Endocrine; 2002 Feb; 17(1):37-42. PubMed ID: 12014702
[TBL] [Abstract][Full Text] [Related]
18. Glucocorticoid-induced osteoporosis: mechanisms for bone loss; evaluation of strategies for prevention.
Mitchell DR; Lyles KW
J Gerontol; 1990 Sep; 45(5):M153-8. PubMed ID: 2203846
[TBL] [Abstract][Full Text] [Related]
19. Chaperonin 60 sustains osteoblast autophagy and counteracts glucocorticoid aggravation of osteoporosis by chaperoning RPTOR.
Lian WS; Ko JY; Chen YS; Ke HC; Wu SL; Kuo CW; Wang FS
Cell Death Dis; 2018 Sep; 9(10):938. PubMed ID: 30224697
[TBL] [Abstract][Full Text] [Related]
20. Cmpk2 regulates mitochondrial function in glucocorticoid-induced osteoblast senescence and affects glucocorticoid-inhibited osteoblast differentiation.
Cao N; Wang Z; Huang C; Chen B; Zhao P; Xu Y; Tian Y
Arch Gerontol Geriatr; 2023 Nov; 114():105080. PubMed ID: 37269696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
